Archford Capital Strategies, LLC Bristol Myers Squibb CO Transaction History

Archford Capital Strategies, LLC

$643 Million
Q4 2024

A detailed history of Archford Capital Strategies, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 11,808 shares of BMY stock, worth $649,203. This represents 0.1% of its overall portfolio holdings.

Number of Shares

11,808

Previous 11,806 0.02%

Holding current value

$649,203

Previous $610,000 9.34%

% of portfolio

0.1%

Previous 0.09%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$51.92 - $59.94 $103 - $119	2 Added 0.02%	11,808 $667,000
Q3 2024 Oct 15, 2024	SELL	$39.66 - $51.75 $317 - $414	-8 Reduced 0.07%	11,806 $610,000
Q2 2024 Jul 17, 2024	SELL	$40.25 - $52.99 $6,882 - $9,061	-171 Reduced 1.43%	11,814 $490,000
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $6,093 - $6,908	127 Added 1.07%	11,985 $649,000
Q4 2023 Jan 12, 2024	SELL	$48.48 - $57.85 $40,723 - $48,594	-840 Reduced 6.62%	11,858 $608,000
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $14,993 - $16,765	-259 Reduced 2.0%	12,698 $736,000
Q2 2023 Aug 02, 2023	SELL	$63.71 - $70.74 $24,910 - $27,659	-391 Reduced 2.93%	12,957 $828,000
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $12,813 - $14,533	195 Added 1.48%	13,348 $925,000
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $616 - $729	9 Added 0.07%	13,153 $0
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $13 - $8,068	105 Added 0.81%	13,144 $934,000
Q2 2022 Jul 12, 2022	BUY	$72.62 - $79.98 $145 - $159	2 Added 0.02%	13,039 $1 Million
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $17,767 - $21,305	289 Added 2.27%	13,037 $970,000
Q4 2021 Jan 20, 2022	SELL	$53.63 - $62.52 $1,394 - $1,625	-26 Reduced 0.2%	12,748 $795,000
Q3 2021 Oct 14, 2021	BUY	$59.17 - $69.31 $7,218 - $8,455	122 Added 0.96%	12,774 $756,000
Q2 2021 Jul 23, 2021	SELL	$61.91 - $67.42 $1,733 - $1,887	-28 Reduced 0.22%	12,652 $845,000
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $1.13 Million - $1.27 Million	-18,994 Reduced 59.97%	12,680 $817,000
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $14,377 - $16,292	-249 Reduced 0.78%	31,674 $1.98 Million
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $55,132 - $61,094	-960 Reduced 2.92%	31,923 $1.93 Million
Q2 2020 Jul 24, 2020	SELL	$54.82 - $64.09 $2,905 - $3,396	-53 Reduced 0.16%	32,883 $1.93 Million
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $423,446 - $615,366	9,126 Added 38.33%	32,936 $1.84 Million
Q4 2019 Jan 15, 2020	BUY	$49.21 - $64.19 $9,300 - $12,131	189 Added 0.8%	23,810 $1.53 Million
Q3 2019 Oct 23, 2019	SELL	$42.77 - $50.71 $3,720 - $4,411	-87 Reduced 0.37%	23,621 $1.2 Million
Q2 2019 Jul 18, 2019	SELL	$44.62 - $49.34 $1,517 - $1,677	-34 Reduced 0.14%	23,708 $1.08 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $4,918 - $5,864	-109 Reduced 0.46%	23,742 $1.13 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $3,852 - $4,995	-79 Reduced 0.33%	23,851 $1.24 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $47,297 - $53,348	-857 Reduced 3.46%	23,930 $1.49 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $56,340 - $70,222	1,115 Added 4.71%	24,787 $1.37 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $186,051 - $214,182	3,105 Added 15.1%	23,672 $1.45 Million
Q4 2017 Feb 16, 2018	SELL	$59.94 - $65.35 $237,482 - $258,916	-3,962 Reduced 16.15%	20,567 $1.26 Million
Q3 2017 Nov 17, 2017	BUY	$55.23 - $63.74 $665,852 - $768,449	12,056 Added 96.66%	24,529 $1.56 Million
Q2 2017 Aug 25, 2017	SELL	N/A	-19,183 Reduced 60.6%	12,473 $695,000
Q2 2017 Aug 18, 2017	BUY	N/A	31,656	31,656 $33,000

Others Institutions Holding BMY

# of Institutions

2,749

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $117B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Account

Archford Capital Strategies, LLC Bristol Myers Squibb CO Transaction History